Edgewise Therapeutics, Inc.
Key Metrics
Market Snapshot
About
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel treatments for severe, rare muscle disorders. The company's lead product candidate is designed to address conditions such as Duchenne muscular dystrophy and other muscle diseases by directly targeting the muscle sarcomere. Edgewise's approach aims to improve muscle function and slow disease progression through orally administered small molecule therapeutics. The company is conducting clinical trials to evaluate the safety and efficacy of its drug candidates in patients with debilitating muscle disorders.